ResMed  logo
ResMed RMD
$ 251.67 -0.27%

Annual report 2022
added 08-12-2022

report update icon

ResMed Cash Flow 2011-2025 | RMD

Annual Cash Flow ResMed

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

351 M 737 M 802 M 459 M 505 M 414 M 548 M - - 403 M 383 M 283 M

Depreciation & Amortization

160 M 157 M 155 M 151 M 120 M 112 M 86.8 M 73.1 M 73.5 M 78.3 M 85.9 M 70.6 M

Accounts Payables

159 M 138 M 136 M 116 M 92.7 M 92.8 M 92.6 M 81.1 M 85.4 M 60.7 M 55 M 55.2 M

Accounts Receivables

576 M 614 M 475 M 528 M 484 M 451 M 382 M 363 M 360 M 318 M 283 M 274 M

Total Inventories

744 M 457 M 417 M 350 M 269 M 268 M 224 M 247 M 165 M 146 M 174 M 201 M

All numbers in USD currency

Quarterly Cash Flow ResMed

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - - - - -65.7 M 154 M - - 144 M 314 M 144 M - 162 M 232 M 162 M - 48.1 M 178 M 48.1 M - 94 M 227 M - - - - - - - - - - - - - - - - - - 78.3 M 172 M - - 89.5 M 200 M 89.5 M

Depreciation & Amortization

- - - 42.3 M 40.8 M 39.1 M 79.9 M 40 M 40.6 M 39.5 M 40.6 M 39.5 M 39.1 M 38 M 77.1 M 38 M 9.2 M 30.4 M 66.5 M 30.4 M - 29.6 M 58.9 M 29.6 M - 27.8 M 55.5 M 27.8 M - 18.4 M 39.9 M 18.4 M - 18.6 M 37.5 M 18.6 M - 17.9 M 36.4 M 17.9 M 2.5 M 18.6 M 37.9 M 18.6 M 3.69 M 20.4 M 43.4 M 20.4 M

Accounts Payables

- - - 150 M 163 M 174 M 138 M 138 M 122 M 118 M 136 M 136 M 114 M 110 M 116 M 116 M 110 M 98.7 M 92.7 M 92.7 M 78.4 M 85.1 M 92.8 M 92.8 M 94.1 M 80.5 M 92.6 M 92.6 M 67.6 M 77.5 M 81.1 M 81.1 M 80 M 76.2 M 85.4 M 85.4 M 56.2 M 57.1 M 60.7 M 60.7 M 52.1 M 52.9 M 55 M 55 M 45.8 M 46.7 M 55.2 M 55.2 M

Accounts Receivables

- - - 509 M 526 M 576 M 614 M 614 M 509 M 465 M 475 M 475 M 528 M 494 M 528 M 528 M 477 M 464 M 484 M 484 M 483 M 431 M 451 M 451 M 384 M 347 M 382 M 382 M 332 M 327 M 363 M 363 M 340 M 329 M 360 M 338 M 302 M 282 M 318 M 318 M 281 M 267 M 283 M 283 M 239 M 251 M 274 M 274 M

Total Inventories

- - - 665 M 592 M 507 M 457 M 457 M 475 M 478 M 417 M 417 M 378 M 357 M 350 M 350 M 297 M 283 M 269 M 269 M 296 M 300 M 268 M 268 M 253 M 254 M 224 M 224 M 237 M 259 M 247 M 247 M 218 M 197 M 165 M 165 M 178 M 175 M 146 M 146 M 195 M 193 M 174 M 174 M 184 M 188 M 201 M 201 M

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company ResMed , reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical instruments sector

Issuer Price % 24h Market Cap Country
BioLife Solutions BioLife Solutions
BLFS
$ 24.56 0.7 % $ 1.13 B usaUSA
Baxter International Baxter International
BAX
$ 19.52 1.93 % $ 9.96 B usaUSA
Becton, Dickinson and Company Becton, Dickinson and Company
BDX
$ 200.48 -0.23 % $ 57.7 B usaUSA
Ekso Bionics Holdings Ekso Bionics Holdings
EKSO
$ 4.68 0.21 % $ 94.4 M usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
$ 0.71 -4.45 % $ 30.1 M usaUSA
ICU Medical ICU Medical
ICUI
$ 148.28 -0.1 % $ 3.62 B usaUSA
iRhythm Technologies iRhythm Technologies
IRTC
$ 170.21 0.82 % $ 5.31 B usaUSA
Alcon Alcon
ALC
$ 79.15 0.43 % $ 40.4 B schweizSchweiz
AtriCure AtriCure
ATRC
$ 41.07 -3.09 % $ 1.93 B usaUSA
Atrion Corporation Atrion Corporation
ATRI
- - $ 810 M usaUSA
electroCore electroCore
ECOR
$ 4.85 2.11 % $ 26.7 K usaUSA
Repro Med Systems Repro Med Systems
KRMD
$ 5.8 0.35 % $ 264 M usaUSA
AngioDynamics AngioDynamics
ANGO
$ 13.42 2.13 % $ 548 M usaUSA
The Cooper Companies The Cooper Companies
COO
$ 81.36 -0.88 % $ 16.2 B usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
$ 83.04 -1.14 % $ 1.86 B usaUSA
Glaukos Corporation Glaukos Corporation
GKOS
$ 111.73 2.6 % $ 5.41 B usaUSA
Masimo Corporation Masimo Corporation
MASI
$ 137.35 -0.72 % $ 7.32 B usaUSA
Haemonetics Corporation Haemonetics Corporation
HAE
$ 80.24 -3.89 % $ 4.04 B usaUSA
InfuSystem Holdings InfuSystem Holdings
INFU
$ 9.22 -0.27 % $ 190 M usaUSA
Merit Medical Systems Merit Medical Systems
MMSI
$ 86.49 -0.24 % $ 5.04 B usaUSA
Isoray Isoray
ISR
- 0.03 % $ 108 M usaUSA
Intuitive Surgical Intuitive Surgical
ISRG
$ 559.7 3.2 % $ 199 B usaUSA
OraSure Technologies OraSure Technologies
OSUR
$ 2.49 - $ 185 M usaUSA
Microbot Medical Microbot Medical
MBOT
$ 2.23 -7.65 % $ 22.7 M israelIsrael
Milestone Scientific Milestone Scientific
MLSS
$ 0.36 -7.4 % $ 28.7 M usaUSA
Nephros Nephros
NEPH
$ 4.98 -0.8 % $ 51.7 M usaUSA
NeuroMetrix NeuroMetrix
NURO
- 5.05 % $ 9.02 M usaUSA
Envista Holdings Corporation Envista Holdings Corporation
NVST
$ 22.07 0.46 % $ 3.8 B usaUSA
Pro-Dex Pro-Dex
PDEX
$ 44.0 1.43 % $ 145 M usaUSA
STAAR Surgical Company STAAR Surgical Company
STAA
$ 23.49 -2.65 % $ 1.15 B usaUSA
STERIS plc STERIS plc
STE
$ 253.98 0.82 % $ 25 B usaUSA
Stereotaxis Stereotaxis
STXS
$ 2.35 -1.05 % $ 190 M usaUSA
Pulse Biosciences Pulse Biosciences
PLSE
$ 14.04 -1.4 % $ 674 M usaUSA
Predictive Oncology Predictive Oncology
POAI
- - $ 32.4 M usaUSA
Repligen Corporation Repligen Corporation
RGEN
$ 160.09 1.72 % $ 8.92 M usaUSA
Utah Medical Products Utah Medical Products
UTMD
$ 57.54 -0.96 % $ 209 M usaUSA
DENTSPLY SIRONA DENTSPLY SIRONA
XRAY
$ 11.43 -1.21 % $ 2.32 B usaUSA
Retractable Technologies Retractable Technologies
RVP
$ 0.84 1.99 % $ 25.1 M usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
$ 126.88 0.17 % $ 5.94 B usaUSA
West Pharmaceutical Services West Pharmaceutical Services
WST
$ 271.82 1.6 % $ 19.8 B usaUSA